Sponsor:
M.D. Anderson Cancer Center
Code:
NCT02727803
Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Acute Biphenotypic Leukemia
Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia in Remission
Acute Myeloid Leukemia With Myelodysplasia-Related Changes
Eligibility Criteria
Sex: All
Age: 15 - 70+
Healthy Volunteers: Not accepted
Interventions
Allogeneic Natural Killer Cell Line NK-92
Anti-Thymocyte Globulin
Busulfan
Clofarabine
Cyclophosphamide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2025-11-06.